Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  21,750 results for ""OXAZOLIDINONES""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Use of oxazolidinones (linezolid or tedizolid) for the treatment of breast infections. A case series from a tertiary referral hospital.

  • Authors : Kirkegaard C; Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Barcelona, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Campus Hospitalari. Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain.; Parramón-Teixidó CJ

Subjects: Tertiary Care Centers* ; Oxazolidinones*/Oxazolidinones*/Oxazolidinones*/therapeutic use ; Linezolid*/Linezolid*/Linezolid*/therapeutic use

  • Source: Infection [Infection] 2024 Aug; Vol. 52 (4), pp. 1585-1593. Date of Electronic Publication: 2024 May 01.Publisher: Springer Heidelberg Country of Publication: Germany NLM ID: 0365307 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Which trial do we need? Empiric Glycopeptides plus clindamycin versus Oxazolidinones for suspected toxic shock and necrotizing soft tissue infections.

  • Authors : Osowicki J; Tropical Diseases Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia; Diseases Unit, Department of General Medicine, Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia

Subjects: Soft Tissue Infections*/Soft Tissue Infections*/Soft Tissue Infections*/drug therapy ; Shock, Septic*/Shock, Septic*/Shock, Septic*/drug therapy ; Glycopeptides*/Glycopeptides*/Glycopeptides*/therapeutic use

  • Source: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2024 May; Vol. 30 (5), pp. Publisher: Elsevier Country of Publication: England NLM ID: 9516420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-0691

Record details

Read More Add to Saved list
×
Academic Journal

Obicetrapib exhibits favorable physiochemical and pharmacokinetic properties compared to previous cholesteryl ester transfer protein inhibitors: An integrated summary of results from non-human primate studies and clinical trials.

  • Authors : Nicholls SJ; Victorian Heart Institute, Monash University, Melbourne, Victoria, Australia.; Nelson AJ

Subjects: Cholesterol Ester Transfer Proteins*/Cholesterol Ester Transfer Proteins*/Cholesterol Ester Transfer Proteins*/antagonists & inhibitors ; Oxazolidinones*/Oxazolidinones*/Oxazolidinones*/pharmacokinetics ; Oxazolidinones*/Oxazolidinones*/Oxazolidinones*/administration & dosage

  • Source: Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Dec; Vol. 12 (6), pp. e70010.Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States

Record details

Read More Add to Saved list
×
Academic Journal

Multicentre evaluation of in vitro activity of contezolid against drug-resistant Staphylococcus and Enterococcus.

  • Authors : Yang W; Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing Dongcheng District, 100730, Beijing, China.; Li X

Subjects: Microbial Sensitivity Tests* ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/pharmacology ; Enterococcus*/Enterococcus*/Enterococcus*/drug effects

  • Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Dec 02; Vol. 79 (12), pp. 3132-3141.Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Differences in oxazolidinone resistance mechanisms and small colony variants emergence of Staphylococcus aureus induced in an in vitro resistance development model.

  • Authors : Staudacher M; Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.; Department of Angiology, Medical University of Vienna, Vienna, Austria.

Subjects: Methicillin-Resistant Staphylococcus aureus* ; Oxazolidinones*/Oxazolidinones*/Oxazolidinones*/pharmacology ; Staphylococcal Infections*/Staphylococcal Infections*/Staphylococcal Infections*/drug therapy

  • Source: Emerging microbes & infections [Emerg Microbes Infect] 2024 Dec; Vol. 13 (1), pp. 2292077. Date of Electronic Publication: 2024 Feb 06.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Oxazolidinone antibiotics impair ex vivo megakaryocyte differentiation from hematopoietic progenitor cells and their maturation into platelets.

  • Authors : Milosevic TV; Pharmacologie cellulaire et moléculaire, Louvain Drug Research Institute, Université catholique de Louvain (UCLouvain), Brussels, Belgium.; Vertenoeil G

Subjects: Oxazolidinones*/Oxazolidinones*/Oxazolidinones*/pharmacology ; Megakaryocytes*/Megakaryocytes*/Megakaryocytes*/drug effects ; Megakaryocytes*/Megakaryocytes*/Megakaryocytes*/cytology

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Oct 08; Vol. 68 (10), pp. e0053324. Date of Electronic Publication: 2024 Sep 19.Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Hybridization of antimicrobial oxazolidinones with commercial drugs: A fight against the "superbugs".

  • Authors : Prasher P; Department of Chemistry, University of Petroleum & Energy Studies, Energy Acres, Dehradun, India.; Sharma M

Subjects: Oxazolidinones*/Oxazolidinones*/Oxazolidinones*/pharmacology ; Oxazolidinones*/Oxazolidinones*/Oxazolidinones*/therapeutic use ; Anti-Infective Agents*/Anti-Infective Agents*/Anti-Infective Agents*/pharmacology

  • Source: Drug development research [Drug Dev Res] 2023 Nov; Vol. 84 (7), pp. 1337-1345. Date of Electronic Publication: 2023 Aug 15.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8204468 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Tricyclic Benzo[1,3]oxazinyloxazolidinones as Potent Antibacterial Agents against Drug-Resistant Pathogens.

  • Authors : Lu H; Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation, Chinese Academy of Medical Sciences Key Laboratory of Anti-DR TB Innovative Drug Research, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China.; Han X

Subjects: Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/pharmacology ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/chemical synthesis ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/chemistry

  • Source: Journal of medicinal chemistry [J Med Chem] 2024 Sep 26; Vol. 67 (18), pp. 16088-16106. Date of Electronic Publication: 2024 Sep 05.Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen.

  • Authors : Strydom N; Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy, University of California, San Francisco, CA, USA.; Ernest JP

Subjects: Linezolid*/Linezolid*/Linezolid*/administration & dosage ; Linezolid*/Linezolid*/Linezolid*/therapeutic use ; Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/administration & dosage

  • Source: Nature communications [Nat Commun] 2024 Aug 25; Vol. 15 (1), pp. 7311. Date of Electronic Publication: 2024 Aug 25.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacokinetic and Pharmacodynamic Modeling Analysis of Delpazolid (LCB01-0371) in Adult Patients with Pulmonary Tuberculosis.

  • Authors : Lee SM; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Choi SC

Subjects: Oxazolidinones*/Oxazolidinones*/Oxazolidinones*/pharmacokinetics ; Oxazolidinones*/Oxazolidinones*/Oxazolidinones*/administration & dosage ; Oxazolidinones*/Oxazolidinones*/Oxazolidinones*/therapeutic use

  • Source: Journal of clinical pharmacology [J Clin Pharmacol] 2024 Jul; Vol. 64 (7), pp. 849-859. Date of Electronic Publication: 2024 Mar 04.Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604

Record details

Read More Add to Saved list
×
  • 1-10 of  21,750 results for ""OXAZOLIDINONES""